Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165110 · ClinicalTrials.gov registry record · NA
Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03165110 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 47 participants.
The verdict
NCT03165110, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the utility of the Contour Diabetes App 2.0 when used with the Contour Next One meter (the Onyx system).
Interventions
- DEVICE Onyx BG Meter / App System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-03-17 |
| Est. Completion | 2017-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03165110
The ClinicalTrials.gov registry entry for NCT03165110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Onyx BG Meter / App System is the first listed.
NCT03165110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03165110 about?
NCT03165110 is a clinical study titled "Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System". The purpose of this study is to assess the utility of the Contour Diabetes App 2.0 when used with the Contour Next One meter (the Onyx system).
What is the current status of trial NCT03165110?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-03-17. Estimated completion is 2017-05-12.
What interventions are being tested in trial NCT03165110?
The interventions under investigation include: Onyx BG Meter / App System (DEVICE).
Who is sponsoring clinical trial NCT03165110?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.